Fora Capital, LLC Charles River Laboratories International, Inc. Transaction History

Fora Capital, LLC

$791 Million
Q2 2024

A detailed history of Fora Capital, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fora Capital, LLC holds 8,987 shares of CRL stock, worth $1.78 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

8,987

Holding current value

$1.78 Million

% of portfolio

0.23%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$206.39 - $268.73 $1.85 Million - $2.42 Million	8,987 New	8,987 $1.86 Million
Q1 2023 May 12, 2023	BUY	$191.89 - $259.92 $1.56 Million - $2.12 Million	8,143 New	8,143 $1.64 Million
Q2 2022 Aug 11, 2022	SELL	$204.13 - $302.4 $477,255 - $707,011	-2,338 Reduced 35.95%	4,166 $891,000
Q1 2022 May 12, 2022	BUY	$255.51 - $362.11 $1.66 Million - $2.36 Million	6,504 New	6,504 $1.89 Million
Q2 2021 Aug 16, 2021	SELL	$294.17 - $371.65 $211,214 - $266,844	-718 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $171,523 - $205,742	-687 Reduced 48.9%	718 $208 Million
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $311,910 - $354,931	1,405 New	1,405 $351,000
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $429,595 - $554,123	-2,447 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $196,799 - $314,176	1,656 Added 209.36%	2,447 $427 Million
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $34,417 - $62,062	348 Added 78.56%	791 $99,000
Q4 2019 Feb 14, 2020	BUY	$126.05 - $152.76 $55,840 - $67,672	443 New	443 $67,000

Others Institutions Holding CRL

# of Institutions

732

Shares Held

51.8M

Call Options Held

233K

Put Options Held

236K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Account